Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 149826, 10 pages
http://dx.doi.org/10.1155/2015/149826
Research Article

Consequence of Menin Deficiency in Mouse Adipocytes Derived by In Vitro Differentiation

Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Received 3 April 2015; Revised 17 June 2015; Accepted 18 June 2015

Academic Editor: Ludwik K. Malendowicz

Copyright © 2015 Vaishali I. Parekh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Chandrasekharappa, S. C. Guru, P. Manickam et al., “Positional cloning of the gene for multiple endocrine neoplasia-type 1,” Science, vol. 276, no. 5311, pp. 404–406, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Lemmens, J. M. van de ven Wim, K. Kas et al., “Identification of the multiple endocrine neoplasia type 1 (MEN1) gene,” Human Molecular Genetics, vol. 6, no. 7, pp. 1177–1183, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. R. V. Thakker, P. J. Newey, G. V. Walls et al., “Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1),” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 9, pp. 2990–3011, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. T. N. Darling, M. C. Skarulis, S. M. Steinberg, S. J. Marx, A. M. Spiegel, and M. Turner, “Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1,” Archives of Dermatology, vol. 133, no. 7, pp. 853–857, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Vidal, M. J. Iglesias, B. Fernández, E. Fonseca, and F. Cordido, “Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1,” Journal of the European Academy of Dermatology and Venereology, vol. 22, no. 7, pp. 835–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Q. Dong, L. V. Debelenko, S. C. Chandrasekharappa et al., “Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1,” The Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1416–1420, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Pack, M. L. Turner, Z. Zhuang et al., “Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene,” The Journal of Investigative Dermatology, vol. 110, no. 4, pp. 438–440, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. O. Vortmeyer, R. Böni, E. Pak, S. Pack, and Z. Zhuang, “Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas,” Journal of the National Cancer Institute, vol. 90, no. 5, pp. 398–399, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Rusconi, E. Valtorta, O. Rodeschini et al., “Combined characterization of a pituitary adenoma and a subcutaneous lipoma in a MEN1 patient with a whole gene deletion,” Cancer Genetics, vol. 204, no. 6, pp. 309–315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Agarwal, “Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies,” International Journal of Endocrine Oncology, vol. 1, no. 2, pp. 153–161, 2014. View at Publisher · View at Google Scholar
  11. S. E. Piret and R. V. Thakker, “Mouse models for inherited endocrine and metabolic disorders,” The Journal of Endocrinology, vol. 211, no. 3, pp. 211–230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Harding, M. C. Lemos, A. A. C. Reed et al., “Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia,” Endocrine-Related Cancer, vol. 16, no. 4, pp. 1313–1327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. K. Agarwal, “Multiple endocrine neoplasia type 1,” Frontiers of Hormone Research, vol. 41, pp. 1–15, 2013. View at Google Scholar
  14. S. Matkar, A. Thiel, and X. Hua, “Menin: a scaffold protein that controls gene expression and cell signaling,” Trends in Biochemical Sciences, vol. 38, no. 8, pp. 394–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Keller, “Embryonic stem cell differentiation: emergence of a new era in biology and medicine,” Genes & Development, vol. 19, no. 10, pp. 1129–1155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Sterneckert, P. Reinhardt, and H. R. Schöler, “Investigating human disease using stem cell models,” Nature Reviews Genetics, vol. 15, no. 9, pp. 625–639, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Novotny, S. Compton, P. P. Liu, F. S. Collins, and S. C. Chandrasekharappa, “In vitro hematopoietic differentiation of mouse embryonic stem cells requires the tumor suppressor menin and is mediated by Hoxa9,” Mechanisms of Development, vol. 126, no. 7, pp. 517–522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. K. Agarwal and R. Jothi, “Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in men1-like tumors,” PLoS ONE, vol. 7, no. 5, Article ID e37952, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. P. Lee, E. G. L. Koh, A. Tay, S. Brenner, and B. Venkatesh, “Highly conserved syntenic blocks at the vertebrate Hox loci and conserved regulatory elements within and outside Hox gene clusters,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 6994–6999, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. R. D. Emes, L. Goodstadt, E. E. Winter, and C. P. Ponting, “Comparison of the genomes of human and mouse lays the foundation of genome zoology,” Human Molecular Genetics, vol. 12, no. 7, pp. 701–709, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. M. K. Alam, R. Ain, T. Konno, J. K. Ho-Chen, and M. J. Soares, “The rat prolactin gene family locus: species-specific gene family expansion,” Mammalian Genome, vol. 17, no. 8, pp. 858–877, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Soares, T. Konno, and S. M. K. Alam, “The prolactin family: effectors of pregnancy-dependent adaptations,” Trends in Endocrinology and Metabolism, vol. 18, no. 3, pp. 114–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-S. Ang, S.-Y. Tsai, D.-F. Lee et al., “Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network,” Cell, vol. 145, no. 2, pp. 183–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Green and O. Kehinde, “An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion,” Cell, vol. 5, no. 1, pp. 19–27, 1975. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Ramírez-Zacarías, F. Castro-Muñozledo, and W. Kuri-Harcuch, “Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O,” Histochemistry, vol. 97, no. 6, pp. 493–497, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Yamaguchi, F. Nishimura, H. Naruishi, Y. Soga, S. Kokeguchi, and S. Takashiba, “Thiazolidinedione (pioglitazone) blocks P. gingivalis- and F. nucleatum, but not E. coli, lipopolysaccharide (LPS)-induced interleukin-6 (IL-6) production in adipocytes,” Journal of Dental Research, vol. 84, no. 3, pp. 240–244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Sakuma, Y. Nishioka, R. Imanishi et al., “cis9, trans11-conjugated linoleic acid differentiates mouse 3T3-L1 preadipocytes into mature small adipocytes through induction of peroxisome proliferator-activated receptor gamma,” Journal of Clinical Biochemistry and Nutrition, vol. 47, no. 2, pp. 167–173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Almendro, G. Fuster, E. Ametller et al., “Interleukin-15 increases calcineurin expression in 3T3-L1 cells: possible involvement on in vivo adipocyte differentiation,” International Journal of Molecular Medicine, vol. 24, no. 4, pp. 453–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Dani, A. G. Smith, S. Dessolin et al., “Differentiation of embryonic stem cells into adipocytes in vitro,” Journal of Cell Science, vol. 110, no. 11, pp. 1279–1285, 1997. View at Google Scholar · View at Scopus
  30. S. K. Karnik, C. M. Hughes, X. Gu et al., “Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 41, pp. 14659–14664, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Balasubramanian, B. Akhtar-Zaidi, L. Song et al., “H3K4me3 inversely correlates with DNA methylation at a large class of non-CpG-island-containing start sites,” Genome Medicine, vol. 4, no. 5, article 47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Wang, C. Lin, E. R. Smith et al., “Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II,” Molecular and Cellular Biology, vol. 29, no. 22, pp. 6074–6085, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. D. Modali, V. I. Parekh, E. Kebebew, and S. K. Agarwal, “Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors,” Molecular Endocrinology, vol. 29, no. 2, pp. 224–237, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. K. M. A. Dreijerink, R. A. Varier, O. van Beekum et al., “The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation,” Molecular and Cellular Biology, vol. 29, no. 18, pp. 5060–5069, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. E. H. Jeninga, O. van Beekum, A. D. J. van Dijk et al., “Impaired peroxisome proliferator-activated receptor γ function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy,” Molecular Endocrinology, vol. 21, no. 5, pp. 1049–1065, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Sowa, H. Kaji, L. Canaff et al., “Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage,” The Journal of Biological Chemistry, vol. 278, no. 23, pp. 21058–21069, 2003. View at Publisher · View at Google Scholar · View at Scopus